EGFR Target Therapy Combined with Gemox for Advanced Biliary Tract Cancers: a Meta-analysis based on RCTs

Background: Controversy exists regarding whether EGFR-targeted therapy combined with GEMOX (gemcitabine and oxaliplatin) provides additional benefits over GEMOX alone for biliary tract cancer patients. Therefore, this meta-analysis of randomized controlled trials (RCTs) was performed to assess the e...

Descripción completa

Detalles Bibliográficos
Autores principales: Cai, Wen, Yuan, Ying, Ge, Weiting, Fan, Yu, Liu, Xue, Wu, Dehao, Hu, Hanguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929093/
https://www.ncbi.nlm.nih.gov/pubmed/29721058
http://dx.doi.org/10.7150/jca.23290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5929093/
https://www.ncbi.nlm.nih.gov/pubmed/29721058
http://dx.doi.org/10.7150/jca.23290

Ejemplares similares